Filter News
Area of Research
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (6)
- 3-D Printing/Advanced Manufacturing (11)
- Artificial Intelligence (5)
- Big Data (1)
- Bioenergy (6)
- Biology (5)
- Biotechnology (1)
- Buildings (4)
- Chemical Sciences (4)
- Clean Water (1)
- Climate Change (1)
- Composites (4)
- Computer Science (17)
- Coronavirus (4)
- Critical Materials (2)
- Cybersecurity (7)
- Decarbonization (1)
- Energy Storage (10)
- Environment (7)
- Exascale Computing (1)
- Frontier (5)
- Fusion (7)
- Grid (4)
- High-Performance Computing (5)
- Isotopes (5)
- ITER (1)
- Machine Learning (2)
- Materials (10)
- Materials Science (15)
- Microscopy (5)
- Nanotechnology (7)
- National Security (3)
- Neutron Science (12)
- Nuclear Energy (3)
- Physics (3)
- Polymers (3)
- Quantum Computing (3)
- Quantum Science (10)
- Security (3)
- Summit (8)
- Sustainable Energy (11)
- Transportation (6)
Media Contacts
A team including researchers from the Department of Energy’s Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett’s esophagus, which affects more than 3 million people in the United States.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
The U.S. Department of Energy announced funding for 12 projects with private industry to enable collaboration with DOE national laboratories on overcoming challenges in fusion energy development.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.